Found 8 hits of ic50 for monomerid = 342487 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Fibroblast growth factor receptor 2
(Homo sapiens (Human)) | BDBM342487
(US9776988, Example 3)Show SMILES COc1cc(CCc2cc(n[nH]2)-c2nc3ccc(cc3[nH]2)C(=O)NC2CCOCC2)cc(OC)c1 Show InChI InChI=1S/C26H29N5O4/c1-33-20-11-16(12-21(15-20)34-2)3-5-19-14-24(31-30-19)25-28-22-6-4-17(13-23(22)29-25)26(32)27-18-7-9-35-10-8-18/h4,6,11-15,18H,3,5,7-10H2,1-2H3,(H,27,32)(H,28,29)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 1.07 | n/a | n/a | n/a | n/a | n/a | n/a |
Celon Pharma S.A.
US Patent
| Assay Description The compounds were dissolved in 100% DMSO, and obtained solutions were serially diluted in reaction buffer (50 mM Tris pH 7.5, 10 mM MgCl2, 0.25 mM E... |
US Patent US9776988 (2017)
BindingDB Entry DOI: 10.7270/Q27946S6 |
More data for this Ligand-Target Pair | |
Fibroblast growth factor receptor 2
(Homo sapiens (Human)) | BDBM342487
(US9776988, Example 3)Show SMILES COc1cc(CCc2cc(n[nH]2)-c2nc3ccc(cc3[nH]2)C(=O)NC2CCOCC2)cc(OC)c1 Show InChI InChI=1S/C26H29N5O4/c1-33-20-11-16(12-21(15-20)34-2)3-5-19-14-24(31-30-19)25-28-22-6-4-17(13-23(22)29-25)26(32)27-18-7-9-35-10-8-18/h4,6,11-15,18H,3,5,7-10H2,1-2H3,(H,27,32)(H,28,29)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.10 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
Article DOI: 10.1016/j.ejmech.2020.112990 BindingDB Entry DOI: 10.7270/Q2WD44HQ |
More data for this Ligand-Target Pair | |
Fibroblast growth factor receptor 1
(Homo sapiens (Human)) | BDBM342487
(US9776988, Example 3)Show SMILES COc1cc(CCc2cc(n[nH]2)-c2nc3ccc(cc3[nH]2)C(=O)NC2CCOCC2)cc(OC)c1 Show InChI InChI=1S/C26H29N5O4/c1-33-20-11-16(12-21(15-20)34-2)3-5-19-14-24(31-30-19)25-28-22-6-4-17(13-23(22)29-25)26(32)27-18-7-9-35-10-8-18/h4,6,11-15,18H,3,5,7-10H2,1-2H3,(H,27,32)(H,28,29)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
Article DOI: 10.1016/j.ejmech.2020.112990 BindingDB Entry DOI: 10.7270/Q2WD44HQ |
More data for this Ligand-Target Pair | |
Fibroblast growth factor receptor 1
(Homo sapiens (Human)) | BDBM342487
(US9776988, Example 3)Show SMILES COc1cc(CCc2cc(n[nH]2)-c2nc3ccc(cc3[nH]2)C(=O)NC2CCOCC2)cc(OC)c1 Show InChI InChI=1S/C26H29N5O4/c1-33-20-11-16(12-21(15-20)34-2)3-5-19-14-24(31-30-19)25-28-22-6-4-17(13-23(22)29-25)26(32)27-18-7-9-35-10-8-18/h4,6,11-15,18H,3,5,7-10H2,1-2H3,(H,27,32)(H,28,29)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 11.3 | n/a | n/a | n/a | n/a | n/a | n/a |
Celon Pharma S.A.
US Patent
| Assay Description The compounds were dissolved in 100% DMSO, and obtained solutions were serially diluted in reaction buffer (50 mM Tris pH 7.5, 10 mM MgCl2, 0.25 mM E... |
US Patent US9776988 (2017)
BindingDB Entry DOI: 10.7270/Q27946S6 |
More data for this Ligand-Target Pair | |
Fibroblast growth factor receptor 3
(Homo sapiens (Human)) | BDBM342487
(US9776988, Example 3)Show SMILES COc1cc(CCc2cc(n[nH]2)-c2nc3ccc(cc3[nH]2)C(=O)NC2CCOCC2)cc(OC)c1 Show InChI InChI=1S/C26H29N5O4/c1-33-20-11-16(12-21(15-20)34-2)3-5-19-14-24(31-30-19)25-28-22-6-4-17(13-23(22)29-25)26(32)27-18-7-9-35-10-8-18/h4,6,11-15,18H,3,5,7-10H2,1-2H3,(H,27,32)(H,28,29)(H,30,31) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 40.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Celon Pharma S.A.
US Patent
| Assay Description The compounds were dissolved in 100% DMSO, and obtained solutions were serially diluted in reaction buffer (50 mM Tris pH 7.5, 10 mM MgCl2, 0.25 mM E... |
US Patent US9776988 (2017)
BindingDB Entry DOI: 10.7270/Q27946S6 |
More data for this Ligand-Target Pair | |
Fibroblast growth factor receptor 3
(Homo sapiens (Human)) | BDBM342487
(US9776988, Example 3)Show SMILES COc1cc(CCc2cc(n[nH]2)-c2nc3ccc(cc3[nH]2)C(=O)NC2CCOCC2)cc(OC)c1 Show InChI InChI=1S/C26H29N5O4/c1-33-20-11-16(12-21(15-20)34-2)3-5-19-14-24(31-30-19)25-28-22-6-4-17(13-23(22)29-25)26(32)27-18-7-9-35-10-8-18/h4,6,11-15,18H,3,5,7-10H2,1-2H3,(H,27,32)(H,28,29)(H,30,31) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 41 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
Article DOI: 10.1016/j.ejmech.2020.112990 BindingDB Entry DOI: 10.7270/Q2WD44HQ |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM342487
(US9776988, Example 3)Show SMILES COc1cc(CCc2cc(n[nH]2)-c2nc3ccc(cc3[nH]2)C(=O)NC2CCOCC2)cc(OC)c1 Show InChI InChI=1S/C26H29N5O4/c1-33-20-11-16(12-21(15-20)34-2)3-5-19-14-24(31-30-19)25-28-22-6-4-17(13-23(22)29-25)26(32)27-18-7-9-35-10-8-18/h4,6,11-15,18H,3,5,7-10H2,1-2H3,(H,27,32)(H,28,29)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
Article DOI: 10.1016/j.ejmech.2020.112990 BindingDB Entry DOI: 10.7270/Q2WD44HQ |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM342487
(US9776988, Example 3)Show SMILES COc1cc(CCc2cc(n[nH]2)-c2nc3ccc(cc3[nH]2)C(=O)NC2CCOCC2)cc(OC)c1 Show InChI InChI=1S/C26H29N5O4/c1-33-20-11-16(12-21(15-20)34-2)3-5-19-14-24(31-30-19)25-28-22-6-4-17(13-23(22)29-25)26(32)27-18-7-9-35-10-8-18/h4,6,11-15,18H,3,5,7-10H2,1-2H3,(H,27,32)(H,28,29)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 70.4 | n/a | n/a | n/a | n/a | n/a | n/a |
Celon Pharma S.A.
US Patent
| Assay Description The compounds were dissolved in 100% DMSO, and obtained solutions were serially diluted in reaction buffer (50 mM Tris pH 7.5, 10 mM MgCl2, 0.25 mM E... |
US Patent US9776988 (2017)
BindingDB Entry DOI: 10.7270/Q27946S6 |
More data for this Ligand-Target Pair | |